Background:Chondrosarcoma is a lethal ossature malignancy that threatens human lives.Poor sensitivity to chemotherapy drugs and the high rate of recrudescence are the bottlenecks of chondrosarcoma treatment.Drug repurposing is a safe,economical and timesaving way to explore new chemotherapy for diseases.Niclosamide,as an approved anthelmintic drug,has been identified as a potential anticancer agent.However,few studies have reported the effect of niclosamide in the treatment of human chondrosarcoma,the mechanisms of niclosamide in chondrosarcoma remains unknown.Objective:To investigate the effect and mechanism of niclosamide in human chondrosarcoma.Methods:PartⅠ:To examine the inhibitory effect of niclosamide on the cell growth and proliferation of SW1353 and CAL78 cell lines,the crystal violet cell viability assay,CCK-8 assay and colony forming assay were performed at following concentrations for 24 h.PartⅡ:To determine the effect of niclosamide on the cell migratory and invasive capacities of SW1353 and CAL78 cells,the wound-healing assay and cell transwell invasive assay were performed at following concentrations for 24 h.PartⅢ:To investigate whether niclosamide could induce the cell apoptosis of SW1353 and CAL78 cells,Annexin V-FITC/PI flow cytometry assay and TUNEL assay were performed after the treatment of niclosamide at indicated concentrations.PartⅣ:To determine the effect of niclosamide on the cell apoptosis and related mechanisms,JC-1 cell mitochondrial membrane potential assay,Seahorse XFp cell mito stress test and western blotting were performed.The effect of niclosamide on mitochondria including mitochondrial membrane potential,oxygen consumption rate was determined by JC-1 and Seahorse cell mito stress assay,respectively.The expression of caspase-3,cleaved caspase-3,caspase-9,cleaved caspase-9,andβ-tubulin levels examined by western blotting.Results:PartⅠ:Niclosamide could inhibit the cell growth and proliferation of SW1353 and CAL78 cell lines.Niclosamide was found to be highly active with IC50 values of 0.5072 and 0.9472μM in SW1353 and CAL78 cells,respectively.PartⅡ:Niclosamide could attenuate the migratory and invasive capacities of SW1353 and CAL78 cell lines.PartⅢ:Niclosamide could induce the cell apoptosis of SW1353 and CAL 78 cells.PartⅣ:Niclosamide could decrease cell mitochondrial membrane potential,inhibit cell mitochondrial respiration and induce the activation of caspase-dependent mitochondrial apoptosis in SW1353 and CAL78 cells.Conclusions:Niclosamide served as a potent tumor inhibitor in chondrosarcoma via the activation of caspase-dependent mitochondrial apoptotic pathway in vitro,which might be an approach to the therapeutic strategy of chondrosarcoma. |